Cubist Systematic Strategies’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	–	–	3353
2024 Q4	–	Hold	0	–	–	–	3457
2024 Q3	–	Hold	0	–	–	–	3459
2024 Q2	–	Hold	0	–	–	–	3609
2024 Q1	–	Sell	-468,821	Closed	-$5.46M	–	4090
2023 Q4	$3.81M	Buy	+468,821	New	+$2.45M	0.05%	1029
2023 Q3	–	Sell	-252,622	Closed	-$1.78M	–	3683
2023 Q2	$1.78M	Sell	252,622 -244,357	-49%	-$1.75M	0.02%	1574
2023 Q1	$3.04M	Sell	496,979 -120,642	-20%	-$832K	0.03%	1332
2022 Q4	$3.95M	Buy	617,621 +160,674	+35%	+$1.25M	0.03%	1243
2022 Q3	$4.38M	Buy	456,947 +186,709	+69%	+$2.15M	0.03%	1208
2022 Q2	$2.98M	Buy	270,238 +54,593	+25%	+$715K	0.02%	1464
2022 Q1	$3.59M	Buy	215,645 +27,860	+15%	+$431K	0.03%	999
2021 Q4	$3.58M	Sell	187,785 -67,514	-26%	-$1.49M	0.03%	881
2021 Q3	$6.3M	Buy	255,299 +254,257	+24,401%	+$5.99M	0.08%	346
2021 Q2	$27K	Sell	1,042 -97,600	-99%	-$2.54M	﹤0.01%	2836
2021 Q1	$3.12M	Buy	98,642 +71,108	+258%	+$2.95M	0.04%	726
2020 Q4	$1.28M	Sell	27,534 -1,317	-5%	-$52.3K	0.02%	1217
2020 Q3	$950K	Sell	28,851 -259,052	-90%	-$7.94M	0.01%	1366
2020 Q2	$7.9M	Buy	+287,903	New	+$9.46M	0.14%	148
2020 Q1	–	Sell	-21,628	Closed	-$599K	–	2288
2019 Q4	$599K	Sell	21,628 -32,439	-60%	-$738K	0.01%	1439
2019 Q3	$984K	Buy	54,067 +49,153	+1,000%	+$1.09M	0.02%	977
2019 Q2	$120K	Sell	4,914 -17,236	-78%	-$260K	﹤0.01%	2192
2019 Q1	$211K	Buy	22,150 +7,765	+54%	+$75.4K	0.01%	1741
2018 Q4	$127K	Buy	+14,385	New	+$139K	0.01%	1702
2018 Q2	–	Sell	-14,284	Closed	-$241K	–	1908
2018 Q1	$241K	Buy	+14,284	New	+$216K	0.01%	1282
2015 Q2	–	Sell	-53,000	Closed	-$642K	–	1919
2015 Q1	$642K	Buy	+53,000	New	+$597K	0.03%	791